Gene therapy may reduce treatment burden associated with AMD

PHILADELPHIA — Existing techniques enable the application of gene therapy for age-related macular degeneration, a clinician said here.“I think we’re in the most exciting period advancing forward with respect to biologics and the treatments of retinal diseases,” Elias Reichel, MD, said at Macula 2014. “The idea is that this is going to last for a prolonged period of time. Hopefully, we’ll avoid some of the issues with the burden of treatment with multiple injections of either small molecules or biologics.”

Full Story →